Prospective, multicenter trial will evaluate a novel preservation technique utilizing the Paragonix SherpaPak® for DCD (Donation after Circulatory Death) hearts
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Prospective, multicenter trial will evaluate a novel preservation technique utilizing the Paragonix SherpaPak® for DCD (Donation after Circulatory Death) hearts